Defence Therapeutics Inc.: Defence's Melanoma Targeted Vaccine A1-Reprogrammed MSC (ARM) Cell Potency Validated

Vancouver, British Columbia--(Newsfile Corp. - January 24, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company

Related Keywords

Canada ,United Kingdom ,Vancouver ,British Columbia ,British ,Canadian ,Sebastien Plouffe ,Defence Therapeutics Inc ,British Columbia Newsfile Corp ,Defence Therapeutics ,Statement Regarding ,Defence ,Herapeutics ,Melanoma ,Argeted ,Vaccine ,Deprogrammed ,Fell ,Potency ,Validated ,